Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

Synthesis and Functionalization of Azetidine‐Containing Small Macrocyclic Peptides

Biocompatible Synthesis of Macrocyclic Thiazol(in)e Peptides

Peptide Macrocyclization via Cu-catalyzed 1,3-Dipolar Cycloaddition of Azomethine Ylides

Diversity-Oriented Synthesis of Cyclic Azapeptides by A 3 -Macrocyclization Provides High-Affinity CD36-Modulating Peptidomimetics.

Crafting Unnatural Peptide Macrocycles via Rh(III)-Catalyzed Carboamidation

Construction of Natural-Product-Like Cyclophane-Braced Peptide Macrocycles Via Sp(3) C-H Arylation

One-Pot Cyclization to Large Peptidomimetic Macrocycles by In Situ-Generated β-Turn-Enforced Folding

Biosynthetic Strategies for Macrocyclic Peptides

Construction of Natural-Product-Like Cyclophane-Braced Peptide Macrocycles via sp3 C-H Arylation.

Head-to-tail Cyclization for the Synthesis of Naturally Occurring Cyclic Peptides on Organophosphorus Small-Molecular Supports

Total Liquid-phase Sythesis, Head-to-tail Cyclization and Synergistic Self-cleavage of Peptide on Small-molecular Supports

Peptide Macrocyclization Through Palladium-Catalyzed Late-Stage C-H Activation.

A general strategy for synthesis of cyclophane-braced peptide macrocycles via palladium-catalysed intramolecular sp3 C−H arylation

Chemoenzymatic tandem cyclization for the facile synthesis of bicyclic peptides

Current Synthetic Approaches to Peptide and Peptidomimetic Cyclization

Macrocyclization of Bioactive Peptides with Internal Thiazole Motifs Via Palladium-Catalyzed C–H Olefination

Synthesis of Cyclophane-Braced Peptide Macrocycles via Palladium-Catalyzed Intramolecular C(sp 3 )–H Arylation of N -Methyl Alanine at C-Termini

Solution- and Solid-Phase Macrocyclization of Peptides by the Ugi-Smiles Multicomponent Reaction: Synthesis of N-Aryl-Bridged Cyclic Lipopeptides

Peptide Macrocycles Developed from Precisely Regulated Multiple Cyclization of Unprotected Peptides

Advancing multicomponent strategies to macrobicyclic peptides

Efficient Enzymatic Cyclization of Disulfide-Rich Peptides by Using Peptide Ligases